| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/07/2001 | CA2392948A1 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof |
| 06/07/2001 | CA2392931A1 Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents |
| 06/07/2001 | CA2392929A1 Novel benzothiadiazine derivatives, preparation method and pharmaceutical compositions containing same |
| 06/07/2001 | CA2392810A1 A rapid acting freeze dired oral pharmaceutical composition for treating migraine |
| 06/07/2001 | CA2392717A1 Cytokine receptor-like polynucleotides, polypeptides, and antibodies |
| 06/07/2001 | CA2392713A1 Novel antidiabetic agents |
| 06/07/2001 | CA2392615A1 Pancreatic stem cells and their use in transplantation |
| 06/07/2001 | CA2392537A1 Compositions and methods for increasing packaging and yields of recombinant adenoviruses using multiple packaging signals |
| 06/07/2001 | CA2392507A1 Arylamine derivatives and their use as anti-telomerase agent |
| 06/07/2001 | CA2392504A1 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 06/07/2001 | CA2392402A1 Transdermal device comprising a reservoir and a matrix containing the same active principle |
| 06/07/2001 | CA2392102A1 Use of a buffer to prevent candida albicans infections on the skin |
| 06/07/2001 | CA2392039A1 New tri-substituted phenyl derivatives and analogues |
| 06/07/2001 | CA2392038A1 Crystalline form of (s)-2 ethoxy-3-[4-(2-{4-methanesulfonyloxyphenyl} ethoxy) phenyl] propanoic acid |
| 06/07/2001 | CA2392035A1 New phenalkyloxy-phenyl derivatives |
| 06/07/2001 | CA2392029A1 Comminuted form of (s)-2-ethoxy-3-[4-(2-{4-methanesulfonyloxyphenyl}ethoxy)phenyl] propanoic acid |
| 06/07/2001 | CA2391646A1 Solid preparation |
| 06/07/2001 | CA2391402A1 Masp-3, a complement-fixing enzyme, and uses for it |
| 06/07/2001 | CA2391096A1 3-methylene steroid derivatives |
| 06/07/2001 | CA2390839A1 Transforming growth factor alpha hiii |
| 06/07/2001 | CA2390226A1 14,15-beta-methylene substituted androgens |
| 06/07/2001 | CA2390113A1 Aminoheterocyclylamides as pesticides and antiparasitic agents |
| 06/07/2001 | CA2389368A1 Compounds, compositions, and methods for stimulating neuronal growth and elongation |
| 06/07/2001 | CA2388529A1 Pesticidal n-heteroaryl alpha-alkoximino-carboxamides |
| 06/07/2001 | CA2388239A1 Neuroprotective agents and methods related thereto |
| 06/07/2001 | CA2387108A1 Anti-prostate stem cell antigen (psca) antibody compositions and methods of use |
| 06/07/2001 | CA2327638A1 Combination of aldose reductase inhibitors and selective serotonin reuptake inhibitors for the treatment of diabetic complications |
| 06/07/2001 | CA2327575A1 Combination of aldose reductase inhibitors and antihypertensive agents for the treatment of diabetic complications |
| 06/06/2001 | EP1104765A2 Process for preparing n,n,6- trimethyl-2 -(4-methylphenyl)- imidazo- 1,2-a] -pyridine-3- acetamide and salts thereof |
| 06/06/2001 | EP1104764A1 1h-imidazopyridine derivatives |
| 06/06/2001 | EP1104762A1 Substituted imidazo 1,2a]azines as selective inhibotors of cox-2 |
| 06/06/2001 | EP1104760A1 Sulfamoylheteroaryl pyrazole compounds as anti-inflammatory/analgesic agents |
| 06/06/2001 | EP1104759A1 Heteroaryl phenyl pyrazole compounds as anti-inflammatory/analgesic agents |
| 06/06/2001 | EP1104758A1 Acetylene derivatives as anti-inflammatory/analgesic agents |
| 06/06/2001 | EP1104755A1 Process for the preparation of (S)-N-tertbutyl-1,2,3,4- tetrahydroisoquinoline-3-carboxamide |
| 06/06/2001 | EP1104674A1 O,o'-dihydroxy azo dyes as medicinal components with TPO-agonistic or -synergetic activity |
| 06/06/2001 | EP1104673A1 A hydrogen carbonate-containing, desintegrating agent-free pharmaceutical composition |
| 06/06/2001 | EP1104672A1 Cosmetic and/or pharmaceutical compositions |
| 06/06/2001 | EP1104653A1 Composition for animals containing a methyl salicylate |
| 06/06/2001 | EP1104475A1 C-myc is activated by beta-catenin and tcf-4 |
| 06/06/2001 | EP1104462A2 Bpc-1: a secreted brain specific protein expressed and secreted by prostate and bladder cancer cells |
| 06/06/2001 | EP1104456A1 Engineered antigen-presenting cells expressing an array of antigens and uses thereof |
| 06/06/2001 | EP1104436A2 Ss-l-2'-deoxy-nucleosides for the treatment of hepatitis b virus |
| 06/06/2001 | EP1104432A1 Vanadium compounds for treating cancer |
| 06/06/2001 | EP1104425A1 Novel thiazolopyrimidine compounds |
| 06/06/2001 | EP1104423A1 Anhydride modified cantharidin analogues useful in the treatment of cancer |
| 06/06/2001 | EP1104422A1 Phenyl xanthine derivatives |
| 06/06/2001 | EP1104421A1 3-(4-amino-5-ethylpyrimidine-2-yl)-1-(2-fluorobenzyl)-1h-pyrazolo 3,4-b]pyridine |
| 06/06/2001 | EP1104420A1 Substituted 1,8-naphthyridin-4(1h)-ones as phosphodiesterase 4 inhibitors |
| 06/06/2001 | EP1104419A1 N-substituted azabicycloheptane derivatives, production and use thereof |
| 06/06/2001 | EP1104418A2 Nematicidal pyrazoles |
| 06/06/2001 | EP1104417A1 Improved omeprazole process and compositions thereof |
| 06/06/2001 | EP1104416A2 Quaternary ammonium salts and their use as anti-hiv agents |
| 06/06/2001 | EP1104415A1 Method of manufacture of 1,3-oxathiolane nucleosides |
| 06/06/2001 | EP1104414A1 Enantioselective synthesis |
| 06/06/2001 | EP1104413A2 Piperidine and piperazine derivatives, process for their preparation and pharmaceutical compounds containing them |
| 06/06/2001 | EP1104412A1 Tace inhibitors |
| 06/06/2001 | EP1104411A1 Calcilytic compounds |
| 06/06/2001 | EP1104410A1 New carboxylic acid derivatives carrying keto side-chains, their production and their use as endothelin-receptor antagonists |
| 06/06/2001 | EP1104408A2 Drug targeting |
| 06/06/2001 | EP1104407A1 Compounds as selective agonists at alpha 2b or 2b/2c adrenergic receptors |
| 06/06/2001 | EP1104404A1 Substituted isoquinoline derivatives and their use as anticonvulsants |
| 06/06/2001 | EP1104403A1 Hydroxy pipecolate hydroxamic acid derivatives as mmp inhibitors |
| 06/06/2001 | EP1104402A1 Pipecolic acid derivatives and their use for vision and memory disorders |
| 06/06/2001 | EP1104309A2 Protected one-vial formulation for nucleic acid molecules, methods of making the same by in-line mixing, and related products and methods |
| 06/06/2001 | EP1104307A2 Pharmaceutical composition having inhibitory effect on overproduction and accumulation of extracellular matrix |
| 06/06/2001 | EP1104302A1 Prophylactic treatments of neovascularisation in macular degeneration |
| 06/06/2001 | EP1104301A1 Method of treatment |
| 06/06/2001 | EP1104300A2 Carboxylic acids and isosteres of heterocyclic ring compounds having multiple heteroatoms for vision and memory disorders |
| 06/06/2001 | EP1104299A2 N-linked urea or carbamate of heterocyclic thioesters for vision and memory disorders |
| 06/06/2001 | EP1104298A2 Heterocyclic thioesters or ketones for vision and memory disorders |
| 06/06/2001 | EP1104297A1 Methods and compositions for the treatment of chronic lymphocytic leukemia |
| 06/06/2001 | EP1104296A1 Bioimplant formulation |
| 06/06/2001 | EP1104295A1 Use of quaternary nitrogen compounds for prophylaxis or treatment of superinfected atopic eczema |
| 06/06/2001 | EP1104294A1 Compositions and methods of treating abnormal cell proliferation |
| 06/06/2001 | EP1104293A1 Regulation of substrate activity |
| 06/06/2001 | EP1104292A2 Treatment of vasodilatory headache |
| 06/06/2001 | EP1104291A1 Pellets having a core coated with an antifungal and a polymer |
| 06/06/2001 | EP1104290A1 Microemulsions as solid dosage forms for oral administration |
| 06/06/2001 | EP1104289A2 New oral formulation for 5-ht4 agonists or antagonists |
| 06/06/2001 | EP1104280A2 Topical delivery systems for active agents |
| 06/06/2001 | EP1104247A1 Process and product for promoting weight loss in overweight dogs |
| 06/06/2001 | EP1104236A1 Transdermally delivered aspirin |
| 06/06/2001 | EP0889891B1 4-[(thien-2-yl)methyl]imidazole derivatives having alpha2-adrenoceptor agonistic activity |
| 06/06/2001 | EP0888346B1 Coralyne analogs as topoisomerase inhibitors |
| 06/06/2001 | EP0883695B1 Method and composition for hair removal |
| 06/06/2001 | EP0881904B1 Topical pharmaceutical composition containing heparin |
| 06/06/2001 | EP0879058B1 Mixtures derived from grains of eugenia jambolana lamarck, preparation and use of said mixtures and some of their constituents as medicaments |
| 06/06/2001 | EP0873329B1 Novel n-aminoalkylfluorenecarboxamides; a new class of dopamine receptor subtype specific ligands |
| 06/06/2001 | EP0802914B1 Aryl- and heteroaryl- purine and pyridopyrimidine derivatives |
| 06/06/2001 | EP0781283B1 Triazolopyridazines process and intermediates for their preparation and their use as medicaments |
| 06/06/2001 | EP0777659B1 Morpholine derivatives and their use as therapeutic agents |
| 06/06/2001 | EP0773786B1 Quinoa saponin compositions and methods of use |
| 06/06/2001 | EP0768887B1 Compositions having antiviral properties and preparation process |
| 06/06/2001 | EP0741728B1 Improved process for synthesizing carbapenem intermediates |
| 06/06/2001 | EP0695752B1 anthraquinonic derivatives having an antitumor activity, and applications thereof |
| 06/06/2001 | EP0690865B1 Crystalline benzathine salt of cefonicid and its preparation |
| 06/06/2001 | EP0681584B1 Condensed heterocyclic glutamic acid derivatives as antiproliferative agents |
| 06/06/2001 | EP0676961B1 Use of macrolides for the treatment of cerebral ischemia |
| 06/06/2001 | CN1298445A Neuropilin antisense oligonucleotide sequences and methods of using same to modulate cell growth |